Jane Street Group, LLC Icosavax, Inc. Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$5.95 - $15.79 $202,186 - $536,559	33,981 New	33,981 $535,000
Q1 2023 May 15, 2023	BUY	$5.62 - $11.51 $91,341 - $187,072	16,253 Added 119.39%	29,866 $173,000
Q4 2022 Feb 14, 2023	SELL	$2.32 - $10.97 $28,570 - $135,095	-12,315 Reduced 47.5%	13,613 $108,000
Q3 2022 Nov 14, 2022	BUY	$3.09 - $9.21 $80,117 - $238,796	25,928 New	25,928 $82,000
Q3 2022 Nov 14, 2022	BUY	$3.09 - $9.21 $80,117 - $238,796	25,928 New	25,928 $82,000

Q2 2022 Aug 16, 2022	SELL	$5.7 - $10.33 $243,760 - $441,762	-42,765 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$4.41 - $22.5 $188,593 - $962,212	42,765 New	42,765 $301,000

1.37M

Ticker ICVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,885,200
Description
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.